9 results
424B5
QNTM
Quantum BioPharma Ltd
16 Feb 24
Prospectus supplement for primary offering
6:36pm
on the Corporation’s ability to market or sell the Corporation’s brands, profitably exploit the Corporation’s unique products or recoup the Corporation’s
F-3
QNTM
Quantum BioPharma Ltd
22 Dec 23
Shelf registration (foreign)
6:49pm
products or recoup the Corporation’s associated research and development costs.
Litigation
The Corporation may from time to time become party to litigation
20-F
2021 FY
QNTM
Quantum BioPharma Ltd
31 Mar 22
Annual report (foreign)
8:09am
country to country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more Product Candidates, even if any Product
40-F
EX-99.1
p9hqh2te3eoy8r
17 Mar 21
Annual report (Canada)
12:00am
40-F
EX-99.1
u7v7mij7tn
4 Mar 20
Annual report (Canada)
12:29pm
40FR12B
EX-99.39
l3wloex
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.47
7vm4lc1
6 Dec 19
Initial registration of securities (Canada)
12:28pm
- Prev
- 1
- Next